BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 26192239)

  • 1. [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients].
    Sun L; Wang Y; Liu Y; Zhao Y; Zhang X; Wang Y; Zhao D; Zhang H; Ma Y
    Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):343-9. PubMed ID: 26192239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An analysis of the serological characteristics of anti-mitochondrial M2 subtype in patients with drug-induced liver injury and primary biliary cholangitis].
    Sun LM; Yan HP; Lou JL; Wang Y; Zhao Y; Yu YH; Zhang HP; Liu YM
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):298-303. PubMed ID: 31082342
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of biochemical markers and autoantibodies in diagnosis of early-stage primary biliary cholangitis.
    Zhu YJ; Li J; Liu YG; Jiang Y; Cheng XJ; Han X; Wang CY; Li J
    World J Gastroenterol; 2023 Sep; 29(34):5075-5081. PubMed ID: 37753365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.
    Li BA; Liu J; Hou J; Tang J; Zhang J; Xu J; Song YJ; Liu AX; Zhao J; Guo JX; Chen L; Wang H; Yang LH; Lu J; Mao YL
    World J Gastroenterol; 2015 Jan; 21(1):283-91. PubMed ID: 25574103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological characteristics of primary biliary cirrhosis patients].
    Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary biliary cirrhosis and hepatitis C virus infection.
    Floreani A; Baragiotta A; Leone MG; Baldo V; Naccarato R
    Am J Gastroenterol; 2003 Dec; 98(12):2757-62. PubMed ID: 14687829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
    Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of indirect immunofluorescence test and immunoblot tests in the evaluation of antinuclear and antimitochondrial antibodies.
    Öztürk Ö; Dos Santos Duarte SD; Balaban HY; Şimşek H; Şener B
    Turk J Med Sci; 2022 Apr; 52(5):1697-1703. PubMed ID: 36422475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of patients with primary biliary cirrhosis and anti-SP100 autoantibody positivity].
    Tang YM; Bao WM; You LY; Jiang HJ; Yang JH
    Zhonghua Gan Zang Bing Za Zhi; 2013 May; 21(5):359-62. PubMed ID: 24025137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution from primary biliary cirrhosis to primary biliary cirrhosis/autoimmune hepatitis overlap syndrome.
    Twaddell WS; Lefkowitch J; Berk PD
    Semin Liver Dis; 2008 Feb; 28(1):128-34. PubMed ID: 18293283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis.
    Hu C; Deng C; Song G; Zhang W; Zhang S; Li X; Li P; Zhang F; Li Y
    Dig Dis Sci; 2011 Nov; 56(11):3357-63. PubMed ID: 21660486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlation of antimitochondrial antibodies.
    Zuber MA; Recktenwald C
    Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients.
    Zografos TA; Gatselis N; Zachou K; Liaskos C; Gabeta S; Koukoulis GK; Dalekos GN
    World J Gastroenterol; 2012 Sep; 18(34):4721-8. PubMed ID: 23002341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis.
    Gabeta S; Norman GL; Liaskos C; Papamichalis PA; Zografos T; Garagounis A; Rigopoulou EI; Dalekos GN
    J Clin Immunol; 2007 Jul; 27(4):378-87. PubMed ID: 17514501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status.
    Alric L; Thebault S; Selves J; Peron JM; Mejdoubi S; Fortenfant F; Vinel JP
    Gastroenterol Clin Biol; 2007 Jan; 31(1):11-6. PubMed ID: 17273127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
    Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
    PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical features of patients with primary biliary cirrhosis].
    He L; Lai Y; Lai L; Luo K; Wang W; Tian Y; Gong G; Zhang M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 40(12):1333-9. PubMed ID: 26739075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody.
    Arakawa Y; Amaki S; Miyakawa H; Sakai T; Gotou I; Tanaka N; Moriyama M; Iwasaki A; Sugitani M; Arakawa Y
    J Gastroenterol; 2004; 39(5):490-5. PubMed ID: 15175950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological analysis of anti-mitochondrial antibody negative primary biliary cholangitis-autoimmune hepatitis overlap syndrome].
    Tan XY; Miao Q; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):376-380. PubMed ID: 31177663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.